Zhejiang Medicine Co Ltd (600216) — Cash Flow Quality Index
Zhejiang Medicine Co Ltd (600216) has a Cash Flow Quality Index of 2.66x as of September 2025. Operating cash flow of CN¥690.77 Million exceeds net income of CN¥259.84 Million, indicating high earnings quality where cash backs reported profits. Explore 600216 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Medicine Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Zhejiang Medicine Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Zhejiang Medicine Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Zhejiang Medicine Co Ltd. For live market cap and the full company financial profile, see how much is Zhejiang Medicine Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥1.89 Billion | CN¥873.38 Million | ▲ +80.1% |
| 2024 | 1.20x | CN¥1.22 Billion | CN¥1.02 Billion | ▼ -18.8% |
| 2023 | 1.48x | CN¥634.31 Million | CN¥429.64 Million | ▲ +2.8% |
| 2022 | 1.44x | CN¥520.60 Million | CN¥362.61 Million | ▲ +11.7% |
| 2021 | 1.29x | CN¥1.14 Billion | CN¥884.56 Million | ▼ -32.6% |
| 2020 | 1.91x | CN¥1.26 Billion | CN¥659.64 Million | ▲ +24.4% |
| 2019 | 1.53x | CN¥447.25 Million | CN¥291.95 Million | ▼ -13.6% |
| 2018 | 1.77x | CN¥579.91 Million | CN¥327.21 Million | ▼ -15.7% |
| 2017 | 2.10x | CN¥503.47 Million | CN¥239.54 Million | ▲ +177.8% |
| 2016 | 0.76x | CN¥336.14 Million | CN¥444.34 Million | ▲ +12.3% |
| 2015 | 0.67x | CN¥106.54 Million | CN¥158.22 Million | ▼ -79.0% |
| 2014 | 3.21x | CN¥549.90 Million | CN¥171.34 Million | ▲ +121.7% |
| 2013 | 1.45x | CN¥655.09 Million | CN¥452.60 Million | ▲ +52.6% |
| 2012 | 0.95x | CN¥807.49 Million | CN¥851.14 Million | ▲ +5.6% |
| 2011 | 0.90x | CN¥912.75 Million | CN¥1.02 Billion | ▼ -21.9% |
| 2010 | 1.15x | CN¥1.32 Billion | CN¥1.14 Billion | ▼ -4.7% |
| 2009 | 1.21x | CN¥1.47 Billion | CN¥1.21 Billion | ▼ -1.7% |
| 2008 | 1.23x | CN¥1.20 Billion | CN¥977.28 Million | ▼ -70.4% |
| 2007 | 4.14x | CN¥227.67 Million | CN¥54.95 Million | ▲ +44.9% |
| 2006 | 2.86x | CN¥169.51 Million | CN¥59.27 Million | ▲ +869.8% |
| 2005 | 0.29x | CN¥25.14 Million | CN¥85.27 Million | ▼ -96.9% |
| 2004 | 9.49x | CN¥107.60 Million | CN¥11.33 Million | ▼ -50.6% |
| 2003 | 19.20x | CN¥66.20 Million | CN¥3.45 Million | ▲ +1347.3% |
| 2002 | 1.33x | CN¥23.13 Million | CN¥17.43 Million | ▼ -79.5% |
| 2001 | 6.48x | CN¥98.25 Million | CN¥15.16 Million | ▲ +1178.3% |
| 2000 | 0.51x | CN¥10.58 Million | CN¥20.87 Million | ▲ +138.4% |
| 1999 | -1.32x | CN¥-51.90 Million | CN¥39.29 Million | ▼ -189.9% |
| 1998 | 1.47x | CN¥57.72 Million | CN¥39.27 Million | — |